# The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

> **NCT00151294** · PHASE4 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 20 (—)

## Conditions studied

- Depression
- Multiple Sclerosis

## Interventions

- **DRUG:** escitalopram oxalate antidepressant

## Key facts

- **NCT ID:** NCT00151294
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151294, "The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00151294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*